Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
99
NCT03709420
A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 13, 2018
Completion: Nov 11, 2020
NCT04686669
A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations
Start: Dec 10, 2020
Completion: Jan 16, 2021